加载中…
Place · Level 3
中草药生物碱 · 植物版二甲双胍声誉 · AMPK 激活机制 · RCT 证据 B 级 · 生物利用度是核心问题
contrast · 4
Natural Ozempic is off by an order of magnitude: berberine takes off 2-5% of body weight, GLP-1 agonists 15-20%. At best it substitutes for metformin, not for a GLP-1 — and the two do not even share a pathway.
Two different pathways
Berberine acts on **AMPK** — the cell's master energy switch. In effect it **tricks that switch into believing the cell is running out of fuel**, flipping the body into spend-less, burn-more-glucose-and-fat mode. That is the route metformin's class takes. GLP-1 drugs take an entirely different one: the incretin receptor — glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, and central satiety signalling. **They share no pathway**, so 'the natural version of' is not a claim that can be made.
Order of magnitude
Put the numbers side by side and the gap is not rhetorical: - Glycaemia: pooling 27 RCTs, berberine lowers HbA1c by about **0.7%** — roughly a starting dose of metformin - Weight: berberine **2-5%**, GLP-1 agonists **15-20%** At best, then, it substitutes for metformin — and on uneven evidence (most trials from China and India). Placed where a GLP-1 belongs, it is an order of magnitude short.
The test
'The natural version of X' comes apart with a general two-question test, and this edge is its cleanest demonstration: 1. **Same pathway?** If not, there is no substitution — just two things that both lower glucose. 2. **How far apart in magnitude?** Same direction is not same tier: 2-5% and 15-20% are both weight loss, and they are not the same event. Only when both questions pass is 'substitute' the right word; passing only the second means same class, lower tier, and only the first means same route, less force.
≠Weight-Loss Supplements Debunk
Berberine works mainly on glucose and lipids; its weight effect is weak (~1-2 kg in meta-analysis). Calling it a natural Ozempic equates two very different magnitudes.
≠IBS
Berberine with neem and oregano oil is sold as a personalised protocol in SIBO clinics, with no RCT behind it and no safety case either. The route is gastroenterology, Rome criteria and red-flag screening.
≠PCOS
Berberine activates AMPK in a direction similar to metformin, which is why it gets offered as a substitute. But its bioavailability is poor and it is contraindicated in pregnancy — which matters especially for PCOS patients whose goal is conception.